Vera Bradley Board Approves Poison Pill Amid Turnaround Efforts

Dow Jones
2024-10-12

By Connor Hart

Vera Bradley's board unanimously approved the adoption of a limited duration shareholder rights plan.

The plan provides for the issuance of one right for each outstanding share of the company's common stock, exercisable if a person, entity or group acquires beneficial ownership of 15% or more of the company's outstanding common stock in a transaction not approved by the board, the company said on Friday.

The purveyor of quilted bags and accessories said that the plan is intended to position the board to fulfill its duties, and ensure that it has sufficient time to make informed judgments in the best interests of the company and its shareholders.

Under the plan, which is set to expire Oct. 11, 2025, each right would allow its holder to buy at the exercise price additional shares of common stock having a market value equal to twice the exercise price, the company said.

The poison pill comes as macroeconomic headwinds continue to dampen the company's turnaround efforts. In its most recent quarter, Vera Bradley lowered its outlook after posting lower profit and sales, dragged down by continued pressure on consumers.

Write to Connor Hart at connor.hart@wsj.com

 

(END) Dow Jones Newswires

October 11, 2024 16:27 ET (20:27 GMT)

Copyright (c) 2024 Dow Jones & Company, Inc.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10